Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancer

嵌合抗原受体 癌症研究 免疫疗法 医学 胰腺癌 免疫系统 抗原 肿瘤微环境 癌症 免疫学 内科学
作者
A. Barrett,Zachary T. Britton,Rosa Carrasco,Shannon Breen,Maria A. S. Broggi,A.L. Hatke,Benjamin Clark,Chunning Yang,Sandrina Phipps,Lorenzo Burgos Ortiz,Brianna L. Janocha,Peter Zanvit,Nicolás A. Giraldo,Philip L. Martin,Jean−Martin Lapointe,Nathalie Harder,Georgina H. Cornish,Bala Attili,Yariv Mazor,Melissa Damschroder,Mark Cobbold,Gordon Moody,Emily E. Bosco
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
标识
DOI:10.1158/1078-0432.ccr-24-1853
摘要

Abstract Purpose: CLDN18.2 is a surface membrane protein crucial for maintaining tight junctions in gastric mucosal cells and is highly expressed in gastric, esophageal, and pancreatic cancers. Thus, CLDN18.2 is suited for exploration as a clinical target for chimeric antigen receptor T-cell (CAR-T) therapy in these indications. Although CAR-T therapies show promise, a challenge faced in their development for solid tumors is the immunosuppressive tumor microenvironment, often characterized by the presence of immune and stromal cells secreting high levels of transforming growth factor beta (TGF-β). Addition of TGF-β armoring can potentially expand CAR-T activity in solid tumors. We report on the preclinical development of a CLDN18.2-targeting CAR-T showing effectiveness in CLDN18.2-positive gastric, esophageal, and pancreatic tumor models. Experimental Design: The lead lentivirus product contains a unique single-chain variable fragment, CD28 and CD3z costimulatory and signaling domains, and dominant negative TGF-β receptor armoring, enhancing targeting and safety and counteracting suppression. We developed a shortened cell manufacturing process to enhance the potency of the final product, AZD6422. Results: AZD6422 exhibited significant antitumor activity and tolerability in multiple patient-derived tumor xenograft models with various CLDN18.2 and TGF-β levels, as determined by immunohistochemistry. Efficacy of armored CAR-Ts in tumor models with elevated TGF-β was increased in vitro and in vivo. In vitro restimulation assays established greater persistence and cytolytic function of AZD6422 compared with a traditionally manufactured CAR-T. Conclusions: AZD6422 was safe and efficacious in patient-derived, CLDN18.2-positive murine models of gastrointestinal cancers. Our data support further clinical development of AZD6422 for patients with these cancers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
直率的宛海完成签到,获得积分10
刚刚
93完成签到 ,获得积分10
1秒前
1秒前
通宵完成签到 ,获得积分10
1秒前
1秒前
2秒前
MiManchi完成签到,获得积分10
2秒前
超帅凡阳发布了新的文献求助10
2秒前
rachel03发布了新的文献求助10
3秒前
称心的半山完成签到,获得积分10
3秒前
胡恒源完成签到,获得积分10
3秒前
hh完成签到,获得积分10
4秒前
飞飞关注了科研通微信公众号
4秒前
大模型应助哈哈嗝采纳,获得10
5秒前
沉默是金12完成签到 ,获得积分0
5秒前
薰硝壤应助lk65734采纳,获得50
5秒前
盐好香完成签到,获得积分10
6秒前
河山大好完成签到,获得积分10
7秒前
情怀应助lsx采纳,获得10
8秒前
1234发布了新的文献求助10
8秒前
liu bo给liu bo的求助进行了留言
8秒前
9秒前
Hello应助yiyiyi采纳,获得10
10秒前
10秒前
静不净完成签到,获得积分10
10秒前
烟花应助2022.20采纳,获得10
10秒前
11秒前
11秒前
12秒前
情怀应助bolunxier采纳,获得10
12秒前
13秒前
西贝完成签到,获得积分10
13秒前
852应助纳米粒子采纳,获得10
13秒前
年轻寒蕾完成签到,获得积分10
14秒前
14秒前
芝芝发布了新的文献求助10
15秒前
小瓶子完成签到,获得积分10
16秒前
快帮我找找发布了新的文献求助100
16秒前
完美世界应助张聪采纳,获得10
16秒前
18秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
A new approach of magnetic circular dichroism to the electronic state analysis of intact photosynthetic pigments 500
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3148856
求助须知:如何正确求助?哪些是违规求助? 2799869
关于积分的说明 7837518
捐赠科研通 2457441
什么是DOI,文献DOI怎么找? 1307837
科研通“疑难数据库(出版商)”最低求助积分说明 628280
版权声明 601685